Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP967155.RA9eJHP10VxfjI4UgEACr6DmpfXjmNdhvICsKGUAa-Ggc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP967155.RA9eJHP10VxfjI4UgEACr6DmpfXjmNdhvICsKGUAa-Ggc130_assertion type Assertion NP967155.RA9eJHP10VxfjI4UgEACr6DmpfXjmNdhvICsKGUAa-Ggc130_head.
- NP967155.RA9eJHP10VxfjI4UgEACr6DmpfXjmNdhvICsKGUAa-Ggc130_assertion description "[GSTT1 active genotype and GSTO1 Asp140Asp and GSTO2 Asp142Asp genotypes may have a prognostic/pharmacogenomic role in patients with muscle invasive bladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP967155.RA9eJHP10VxfjI4UgEACr6DmpfXjmNdhvICsKGUAa-Ggc130_provenance.
- NP967155.RA9eJHP10VxfjI4UgEACr6DmpfXjmNdhvICsKGUAa-Ggc130_assertion evidence source_evidence_literature NP967155.RA9eJHP10VxfjI4UgEACr6DmpfXjmNdhvICsKGUAa-Ggc130_provenance.
- NP967155.RA9eJHP10VxfjI4UgEACr6DmpfXjmNdhvICsKGUAa-Ggc130_assertion SIO_000772 24040330 NP967155.RA9eJHP10VxfjI4UgEACr6DmpfXjmNdhvICsKGUAa-Ggc130_provenance.
- NP967155.RA9eJHP10VxfjI4UgEACr6DmpfXjmNdhvICsKGUAa-Ggc130_assertion wasDerivedFrom befree-20150227 NP967155.RA9eJHP10VxfjI4UgEACr6DmpfXjmNdhvICsKGUAa-Ggc130_provenance.
- NP967155.RA9eJHP10VxfjI4UgEACr6DmpfXjmNdhvICsKGUAa-Ggc130_assertion wasGeneratedBy ECO_0000203 NP967155.RA9eJHP10VxfjI4UgEACr6DmpfXjmNdhvICsKGUAa-Ggc130_provenance.